Terms: = Breast cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Prognosis
18 results:
1. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
Salaün H; Djerroudi L; Haik L; Schnitzler A; Bataillon G; Deniziaut G; Bièche I; Vincent-Salomon A; Debled M; Cottu P
J Pathol Clin Res; 2024 May; 10(3):e12372. PubMed ID: 38563252
[TBL] [Abstract] [Full Text] [Related]
2. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.
Papadakos KS; Ekström A; Slipek P; Skourti E; Reid S; Pietras K; Blom AM
J Exp Clin Cancer Res; 2022 Dec; 41(1):363. PubMed ID: 36578014
[TBL] [Abstract] [Full Text] [Related]
3. Hereditary pancreatic cancer.
Abe K; Kitago M; Kitagawa Y; Hirasawa A
Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650
[TBL] [Abstract] [Full Text] [Related]
4. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
[TBL] [Abstract] [Full Text] [Related]
5. Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an
Parachoniak CA; Rankin A; Gaffney B; Hartmaier R; Spritz D; Erlich RL; Miller VA; Morosini D; Stephens P; Ross JS; Keech J; Chmielecki J
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28550065
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
Leo F; Bartels S; Mägel L; Framke T; Büsche G; Jonigk D; Christgen M; Lehmann U; Kreipe H
Virchows Arch; 2016 Aug; 469(2):191-201. PubMed ID: 27220763
[TBL] [Abstract] [Full Text] [Related]
7. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study.
Ross JS; Gay LM; Nozad S; Wang K; Ali SM; Boguniewicz A; Khaira D; Johnson A; Elvin JA; Vergilio JA; Suh J; Miller VA; Stephens PJ
Breast Cancer Res Treat; 2016 Jan; 155(2):405-13. PubMed ID: 26762307
[TBL] [Abstract] [Full Text] [Related]
8. Loss of lkb1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.
Li J; Liu J; Li P; Mao X; Li W; Yang J; Liu P
J Exp Clin Cancer Res; 2014 Sep; 33(1):70. PubMed ID: 25178656
[TBL] [Abstract] [Full Text] [Related]
9. lkb1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.
Bouchekioua-Bouzaghou K; Poulard C; Rambaud J; Lavergne E; Hussein N; Billaud M; Bachelot T; Chabaud S; Mader S; Dayan G; Treilleux I; Corbo L; Le Romancer M
Int J Cancer; 2014 Sep; 135(6):1307-18. PubMed ID: 24615515
[TBL] [Abstract] [Full Text] [Related]
10. Hereditary genes and SNPs associated with breast cancer.
Mahdi KM; Nassiri MR; Nasiri K
Asian Pac J Cancer Prev; 2013; 14(6):3403-9. PubMed ID: 23886119
[TBL] [Abstract] [Full Text] [Related]
11. Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer.
Loi S; Michiels S; Lambrechts D; Fumagalli D; Claes B; Kellokumpu-Lehtinen PL; Bono P; Kataja V; Piccart MJ; Joensuu H; Sotiriou C
J Natl Cancer Inst; 2013 Jul; 105(13):960-7. PubMed ID: 23739063
[TBL] [Abstract] [Full Text] [Related]
12. lkb1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest.
Morton JP; Jamieson NB; Karim SA; Athineos D; Ridgway RA; Nixon C; McKay CJ; Carter R; Brunton VG; Frame MC; Ashworth A; Oien KA; Evans TR; Sansom OJ
Gastroenterology; 2010 Aug; 139(2):586-97, 597.e1-6. PubMed ID: 20452353
[TBL] [Abstract] [Full Text] [Related]
13. Tumor suppression by lkb1: SIK-ness prevents metastasis.
Shaw RJ
Sci Signal; 2009 Sep; 2(86):pe55. PubMed ID: 19724060
[TBL] [Abstract] [Full Text] [Related]
14. lkb1 catalytic activity contributes to estrogen receptor alpha signaling.
Nath-Sain S; Marignani PA
Mol Biol Cell; 2009 Jun; 20(11):2785-95. PubMed ID: 19369417
[TBL] [Abstract] [Full Text] [Related]
15. Germline mutation of the lkb1/stk11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome.
Nakanishi C; Yamaguchi T; Iijima T; Saji S; Toi M; Mori T; Miyaki M
Oncology; 2004; 67(5-6):476-9. PubMed ID: 15714005
[TBL] [Abstract] [Full Text] [Related]
16. Peutz-Jeghers syndrome: genetic screening.
Leggett BA; Young JP; Barker M
Expert Rev Anticancer Ther; 2003 Aug; 3(4):518-24. PubMed ID: 12934663
[TBL] [Abstract] [Full Text] [Related]
17. The tumor suppressor gene lkb1 is associated with prognosis in human breast carcinoma.
Shen Z; Wen XF; Lan F; Shen ZZ; Shao ZM
Clin Cancer Res; 2002 Jul; 8(7):2085-90. PubMed ID: 12114407
[TBL] [Abstract] [Full Text] [Related]
18. The molecular basis and clinical aspects of Peutz-Jeghers syndrome.
Hemminki A
Cell Mol Life Sci; 1999 May; 55(5):735-50. PubMed ID: 10379360
[TBL] [Abstract] [Full Text] [Related]